If Momentum and Growth investors thought they were escaping 2020 unscathed, they learned otherwise on Monday. Pfizer’s promising news about a COVID-19 vaccine was met with universal excitement and investors rearranging portfolios—taking gains in long-term winners and plowing into beaten-down cyclical stocks.
Nov
13
2020
Momentum’s Terrible, Horrible, No Good, Very Bad Day!
Login
For full access, please enter your credentials.
About The Author
![Greg Swenson / Sr. Research Analyst & Co-Portfolio Manager](https://leuthold.imgix.net/leutholdgroup.com/site_files/authors/DSC_4236_LR_Greg.jpg?h=150&w=150&fit=crop&fp-y=.15)